These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 14710533)
1. [The effect of neuroleptics on the social behavior disorders of schizophrenic patients]. Mahé V Encephale; 2003 Sep; 29(Pt 2):S28-30. PubMed ID: 14710533 [No Abstract] [Full Text] [Related]
2. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765 [TBL] [Abstract][Full Text] [Related]
3. Drug compliance and cognitive-behavioral therapy in schizophrenia. Lecompte D Acta Psychiatr Belg; 1995; 95(2):91-100. PubMed ID: 8525853 [TBL] [Abstract][Full Text] [Related]
4. [Progress in the development of new generation antipsychotic agents and cognitive behavior therapy for patients with schizophrenia]. Ikebuchi H Seishin Shinkeigaku Zasshi; 2001; 103(12):1022-9. PubMed ID: 11925839 [No Abstract] [Full Text] [Related]
7. [Education groups in neuroleptic treatment of schizophrenic patients]. Gaillard P; Degiovanni A; Parrot F Ann Med Psychol (Paris); 1993 Apr; 151(4):340-2. PubMed ID: 7904433 [No Abstract] [Full Text] [Related]
11. [The course of schizophrenic psychoses treated with neuroleptics]. Rüther E; Nedopil N; Strauss A MMW Munch Med Wochenschr; 1981 May; 123(19):803-4. PubMed ID: 6112707 [No Abstract] [Full Text] [Related]
12. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Heinrichs RW Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745 [No Abstract] [Full Text] [Related]
13. [A model of integrated therapy in the case of mutism in a chronic schizophrenic]. Gattoni T Minerva Psichiatr; 1992; 33(4):335-8. PubMed ID: 1363675 [No Abstract] [Full Text] [Related]
14. [Cognitive deficits in schizophrenia and other psychotic disorders]. Fagerlund B; Glenthøj BY Ugeskr Laeger; 2008 Nov; 170(46):3770-2. PubMed ID: 19014728 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of schizophrenia]. Bitter I Orv Hetil; 2004 Jun; 145(24):1281-3. PubMed ID: 15264758 [No Abstract] [Full Text] [Related]
16. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455 [TBL] [Abstract][Full Text] [Related]
17. [Community mental health care for schizophrenia with social behavior and cognitive dysfunction]. Fujii C; Mizuno M; Nemoto T; Yamasawa R; Kobayashi H; Sakuma H Seishin Shinkeigaku Zasshi; 2009; 111(3):330-4. PubMed ID: 19499645 [No Abstract] [Full Text] [Related]
18. [Changes in the symptomatological picture of schizophrenia in relation to the introduction of neuroleptics]. Modrzewska K Psychiatr Pol; 1988; 22(5):349-55. PubMed ID: 2907659 [No Abstract] [Full Text] [Related]
19. [From neuroleptics toward antipsychotics: quality of life and schizophrenia]. Lançon C Encephale; 2003 Sep; 29(Pt 2):S43-6. PubMed ID: 14710537 [No Abstract] [Full Text] [Related]
20. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series. Christodoulides T; Dudley R; Brown S; Turkington D; Beck AT Psychol Psychother; 2008 Jun; 81(Pt 2):199-207. PubMed ID: 18230197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]